Alkem Laboratories has completed the transfer of its trade generics business to Alkem Wellness Limited, a wholly-owned subsidiary, effective from October 1, 2025. The final sale consideration of Rs. 532.5 crores has been received, with Rs. 32.5 crores paid on December 30, 2025. The transfer was executed through a Business Transfer Agreement dated September 26, 2025.
Transfer Completion
Alkem Laboratories announced the completion of the transfer of its trade generics business to Alkem Wellness Limited. This transfer, structured as a slump sale, was previously communicated to the stock exchanges on December 10, 2024, and September 26, 2025.
Financial Details
The final sale consideration for the transfer of the trade generics business totals Rs. 532.5 crores. Alkem Wellness Limited has paid a balance of Rs. 32.5 crores to Alkem Laboratories on December 30, 2025, completing the transaction as per the Business Transfer Agreement dated September 26, 2025. The effective date of the business transfer was October 1, 2025.
Source: BSE
